# POTASSIUM CHLORIDE
> **ANDA207528** · Abbreviated New Drug Application (Generic) · Sponsor: SIGMAPHARM LABS LLC · Approved 2016-08-19
## Drug
- **FDA Application Number:** ANDA207528
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POTASSIUM CHLORIDE
- **Generic name:** Potassium Chloride
- **Active ingredients:** POTASSIUM CHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SIGMAPHARM LABS LLC
- **First approval:** 2016-08-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207528)
---
*AI Analytics · CC0 1.0*